SIGA Technologies Inc. (SIGA): Price and Financial Metrics
GET POWR RATINGS... FREE!
SIGA POWR Grades
- Growth is the dimension where SIGA ranks best; there it ranks ahead of 99.11% of US stocks.
- SIGA's strongest trending metric is Quality; it's been moving down over the last 178 days.
- SIGA ranks lowest in Stability; there it ranks in the 0th percentile.
SIGA Stock Summary
- The ratio of debt to operating expenses for SIGA TECHNOLOGIES INC is higher than it is for about only 0.52% of US stocks.
- Over the past twelve months, SIGA has reported earnings growth of 541.51%, putting it ahead of 96.71% of US stocks in our set.
- As for revenue growth, note that SIGA's revenue has grown 283.24% over the past 12 months; that beats the revenue growth of 96.73% of US companies in our set.
- Stocks that are quantitatively similar to SIGA, based on their financial statements, market capitalization, and price volatility, are HSTO, NURO, RNWK, KMDA, and FEIM.
- SIGA's SEC filings can be seen here. And to visit SIGA TECHNOLOGIES INC's official web site, go to www.siga.com.
SIGA Valuation Summary
- SIGA's EV/EBIT ratio is 3.8; this is 55.81% lower than that of the median Healthcare stock.
- Over the past 236 months, SIGA's price/sales ratio has gone down 40.3.
Below are key valuation metrics over time for SIGA.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| SIGA | 2022-11-25 | 3.0 | 3.7 | 6.0 | 3.8 |
| SIGA | 2022-11-23 | 3.1 | 3.9 | 6.2 | 4.0 |
| SIGA | 2022-11-22 | 3.2 | 3.9 | 6.3 | 4.1 |
| SIGA | 2022-11-21 | 3.1 | 3.9 | 6.2 | 4.0 |
| SIGA | 2022-11-18 | 3.1 | 3.8 | 6.2 | 4.0 |
| SIGA | 2022-11-17 | 3.1 | 3.9 | 6.2 | 4.1 |
SIGA Growth Metrics
- Its 3 year net cashflow from operations growth rate is now at -5.73%.
- Its year over year revenue growth rate is now at 9.63%.
- The 3 year net income to common stockholders growth rate now stands at -83.93%.
The table below shows SIGA's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 214.7747 | 65.81985 | 107.9236 |
| 2022-06-30 | 147.4098 | 72.22988 | 71.76968 |
| 2022-03-31 | 139.396 | 73.00736 | 69.90182 |
| 2021-12-31 | 133.6705 | 11.49464 | 69.45077 |
| 2021-09-30 | 56.04256 | 41.33845 | 16.40516 |
| 2021-06-30 | 95.4578 | 71.04887 | 43.70648 |
SIGA's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SIGA has a Quality Grade of A, ranking ahead of 98.42% of graded US stocks.
- SIGA's asset turnover comes in at 0.402 -- ranking 116th of 682 Pharmaceutical Products stocks.
- INFI, TTNP, and PALI are the stocks whose asset turnover ratios are most correlated with SIGA.
The table below shows SIGA's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.402 | 0.899 | 0.927 |
| 2021-06-30 | 0.677 | 0.883 | 1.972 |
| 2021-03-31 | 0.924 | 0.883 | 2.388 |
| 2020-12-31 | 0.943 | 0.882 | 2.253 |
| 2020-09-30 | 0.632 | 0.884 | 1.360 |
| 2020-06-30 | 0.346 | 0.896 | 0.269 |
SIGA Stock Price Chart Interactive Chart >
SIGA Price/Volume Stats
| Current price | $8.99 | 52-week high | $26.99 |
| Prev. close | $8.81 | 52-week low | $5.84 |
| Day low | $8.70 | Volume | 985,500 |
| Day high | $9.06 | Avg. volume | 5,572,263 |
| 50-day MA | $9.48 | Dividend yield | N/A |
| 200-day MA | $10.91 | Market Cap | 656.49M |
SIGA Technologies Inc. (SIGA) Company Bio
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.
Latest SIGA News From Around the Web
Below are the latest news stories about SIGA TECHNOLOGIES INC that investors may wish to consider to help them evaluate SIGA as an investment opportunity.
Here's Why SIGA Technologies (NASDAQ:SIGA) Has Caught The Eye Of InvestorsThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even... |
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2022- Approximately $61 Million of International Sales in the Third Quarter – - Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2022. “With significant international sales, our third quarter financial results continue a trend of substantial financial diversification at SIGA,” said |
Monkeypox remains a global health emergency – WHOAn expert panel of the World Health Organization (WHO) has agreed to keep the emergency designation for the ongoing monkeypox outbreak, the global body announced on Tuesday. In July, WHO called the multi-country outbreak a public health emergency of international concern (PHEIC), aiming to generate a coordinated global response against the virus. PHEIC designation, the agency’s highest level of warning, previously issued for the COVID-19 pandemic and Ebola, is intended to unlock funding to share vaccines and therapeutics. At a meeting in October, WHO’s Emergency Committee, however, noted the recent progress made to contain the virus, which has led to over 77K confirmed cases, including 23 deaths globally this year, according to data from the Seeking Alpha | November 1, 2022 |
SIGA Technologies to Host Business Update Call on November 3rd, 2022 Following Release of Third Quarter 2022 Financial ResultsNEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, November 3rd, 2022. Participating on the call will be Dr. Phil Gomez, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at www.siga.com und |
Dear Revlon (REV) Stock Fans, Prepare for DelistingREV stock will be delisted soon. |
SIGA Price Returns
| 1-mo | -2.71% |
| 3-mo | -40.38% |
| 6-mo | -30.15% |
| 1-year | 10.44% |
| 3-year | 83.47% |
| 5-year | 87.68% |
| YTD | 19.55% |
| 2021 | 3.44% |
| 2020 | 52.41% |
| 2019 | -39.62% |
| 2018 | 62.89% |
| 2017 | 68.40% |
Continue Researching SIGA
Here are a few links from around the web to help you further your research on Siga Technologies Inc's stock as an investment opportunity:Siga Technologies Inc (SIGA) Stock Price | Nasdaq
Siga Technologies Inc (SIGA) Stock Quote, History and News - Yahoo Finance
Siga Technologies Inc (SIGA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...